Cue Biopharma appoints CBO Lucinda Warren as CFO effective Feb 9, 2026

Cue Biopharma, Inc.

Lucinda Warren, previously CBO, named Chief Financial & Business Officer; assumes principal financial/accounting officer duties.
Warren had been CBO since Sept 2024; prior VP Business Development at Johnson & Johnson (2014-2024).
No additional compensation or changes to her employment agreement for the CFO role.
No family relationships with directors/officers; no reportable transactions under Item 404(a).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.